Bursting with up-to-date contact details from across the sector, as well as exclusive educational content, our 2019 directory-diary is the region’s only all-in-one, go-to guide. Don’t miss out on your FREE copy! For more information, or to sign up for your complimentary edition, visit http://nihealthcare.com/2019-directory-diary.
Learning from the incidents handled by the PDA, MORPh is delivering free risk management training for PDA members working in primary care, and GP practice-based pharmacists. Primary care pharmacy is an established branch of the profession, and primary care pharmacists have considerable experience working both at a primary care organisation and GP practice based levels [...]
Researchers at Dartmouth, Stanford University, and IBM Research, conducted a critical review of existing literature to determine whether social media big data can be used to understand communication and behavioural patterns related to prescription drug abuse. Their study found that with proper research methods and attention to privacy and ethical issues, social media big data [...]
The US Food and Drug Administration (FDA) has expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have spread (metastasised), and whose tumours have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat [...]
